Highlights Telesis Bio, Inc.

Equities

TBIO

US1920032000

Real-time Estimate Cboe BZX Other stock markets 12:00:46 2024-05-23 pm EDT			5-day change	1st Jan Change
3.535 ^USD	-8.42%		-17.01%	-49.74%

May. 09	Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M	MT
May. 09	Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M	May. 09	MT
Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Telesis Bio Inc. Announces Strategic Focus on Game-Changing Gibson Sola Enzymatic DNA Synthesis Platform and BioXp mRNA Solutions	Apr. 18	CI
Earnings Flash (TBIO) TELESIS BIO Reports Q4 Revenue $7M	Mar. 28	MT
Telesis Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 28	CI
Telesis Bio, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 26	CI
Earnings Flash (TBIO) TELESIS BIO Posts Q3 Revenue $5.6M, vs. Street Est of $7.4M	Nov. 13	MT
Telesis Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Telesis Bio, Inc. Provides Earnings Guidance for 2023	Nov. 13	CI
Earnings Flash (TBIO) TELESIS BIO Posts Q2 Revenue $8.7M, vs. Street Est of $8.6M	23-08-10	MT
Telesis Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Telesis Bio Q1 Loss Narrows While Sales Increase	23-05-12	MT
Translate Bio Shares Plunge 24% After Hours; Q1 Revenue Misses Expectations But Net Loss Narrows in Line With Consensus	23-05-11	MT
Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Earnings Flash (TBIO) TELESIS BIO Posts Q1 Revenue $6.3M, vs. Street Est of $7.4M	23-05-11	MT
Earnings Flash (TBIO) TELESIS BIO Posts Q1 Revenue $6.3M, vs. Street Est of $7.4M	23-05-11	MT
Telesis Bio Inc. Releases Bioxp® Select Kits to Enable DNA Amplification and Scale-Up	23-03-31	CI
Telesis Bio, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-21	CI
Telesis Bio, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-21	CI
Earnings Flash (TBIO) TELESIS BIO Posts Q4 Revenue $9.5M, vs. Street Est of $7.2M	23-03-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Telesis Bio, Inc.

Equities

TBIO

US1920032000

Highlights

Filters